A Rapid 10-minute Liver MRI

This study is ongoing, but not recruiting participants.
Philips Medical Systems
Bracco Diagnostics, Inc
Information provided by (Responsible Party):
Shahid Hussain, MD, University of Nebraska
ClinicalTrials.gov Identifier:
First received: July 6, 2011
Last updated: November 21, 2013
Last verified: November 2013

The purpose of this study to assess the image quality of the rapid MRI compared to the standard MRI.

Underlying Liver Disease
Fibrosis of Liver
Cirrhosis With Suspicion of Liver Cancer
Lesion on a Prior Ultrasound, CT or Outside MRI

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Rapid 10-minute Liver MRI

Resource links provided by NLM:

Further study details as provided by University of Nebraska:

Primary Outcome Measures:
  • image quality outcome [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Two MRI exams will be evaluated by two radiologists based on a number of items.

Estimated Enrollment: 22
Study Start Date: July 2011
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
subjects with an underlying liver disease
(1)underlying liver disease; (2) have a lesion on a prior imaging study; (3) must be prior standard MR


Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with an underlying liver disease


Inclusion Criteria:

  1. underlying liver disease
  2. have a lesion on a prior imaging study
  3. must have prior standard MR

Exclusion Criteria:

  1. Contra-indication for MR imaging including pacemaker, claustrophobia, pregnancy, electronic or vascular devices that are contraindicated;
  2. patients with severe kidney dysfunction
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01390194

United States, Nebraska
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198-1045
Sponsors and Collaborators
University of Nebraska
Philips Medical Systems
Bracco Diagnostics, Inc
Principal Investigator: Shahid Hussain, MD University of Nebraska
  More Information

No publications provided

Responsible Party: Shahid Hussain, MD, Principal Investigator, University of Nebraska
ClinicalTrials.gov Identifier: NCT01390194     History of Changes
Other Study ID Numbers: 246-10
Study First Received: July 6, 2011
Last Updated: November 21, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
liver disease
hepatocellular carcinoma

Additional relevant MeSH terms:
Liver Diseases
Liver Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on October 29, 2014